BioLife Solutions (BLFS) News Today $22.23 +0.15 (+0.68%) As of 02:58 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Russell Investments Group Ltd. Lowers Stock Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Russell Investments Group Ltd. trimmed its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 38.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 272,262 shares of the medicApril 15 at 4:41 AM | marketbeat.comInvesco Ltd. Boosts Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Invesco Ltd. lifted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,239,469 shares of the medical equipment provider'April 15 at 4:07 AM | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Bought by Next Century Growth Investors LLCNext Century Growth Investors LLC increased its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 66.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 310,658 shares of the medical equipmApril 14 at 7:35 AM | marketbeat.comVanguard Group Inc. Has $73.63 Million Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)Vanguard Group Inc. lowered its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 0.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,836,257 shares of the medicalApril 13 at 3:40 AM | marketbeat.comAby J. Mathew Sells 569 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockApril 12 at 5:56 AM | insidertrades.comBioLife Solutions (NASDAQ:BLFS) Raised to "Hold" at StockNews.comStockNews.com upgraded shares of BioLife Solutions from a "sell" rating to a "hold" rating in a report on Tuesday.April 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Takes Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Massachusetts Financial Services Co. MA acquired a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 762,903 shares of the medical equipment provider's stock, valuedApril 8, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Upgraded by StockNews.com to Hold RatingApril 8, 2025 | americanbankingnews.comBioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables CompanyApril 7, 2025 | prnewswire.comBioLife Solutions Stock: Back On Track, But Still ExpensiveApril 6, 2025 | seekingalpha.comBioLife Solutions: A Steady Stock Lined Up For Success In A Booming IndustryApril 6, 2025 | seekingalpha.comSarah Aebersold Sells 5,771 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 5,771 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.66, for a total value of $130,770.86. Following the completion of the sale, the insider now owns 80,094 shares in the company, valued at $1,814,930.04. This represents a 6.72 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.April 5, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CMO Todd Berard Sells 8,902 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 8,902 shares of the company's stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.66, for a total value of $201,719.32. Following the sale, the chief marketing officer now owns 135,956 shares in the company, valued at approximately $3,080,762.96. This trade represents a 6.15 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.April 5, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) EVP Aby J. Mathew Sells 10,589 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 10,589 shares of the firm's stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $22.66, for a total transaction of $239,946.74. Following the completion of the transaction, the executive vice president now directly owns 309,576 shares of the company's stock, valued at approximately $7,014,992.16. The trade was a 3.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.April 5, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells $582,067.42 in StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 25,687 shares of BioLife Solutions stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $22.66, for a total transaction of $582,067.42. Following the completion of the sale, the chief financial officer now owns 189,242 shares in the company, valued at approximately $4,288,223.72. This represents a 11.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.April 5, 2025 | marketbeat.comSarah Aebersold Sells 5,771 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockApril 4, 2025 | insidertrades.comBioLife Solutions, Inc. (NASDAQ:BLFS) Receives Consensus Rating of "Buy" from AnalystsBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has received a consensus recommendation of "Buy" from the seven analysts that are covering the stock, Marketbeat Ratings reports. Seven analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that havApril 4, 2025 | marketbeat.comNotable Two Hundred Day Moving Average Cross - BLFSApril 2, 2025 | nasdaq.comBioLife Solutions (NASDAQ:BLFS) Lowered to Sell Rating by StockNews.comStockNews.com downgraded shares of BioLife Solutions from a "hold" rating to a "sell" rating in a report on Monday.April 1, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Trading Down 7.7% - Here's WhyBioLife Solutions (NASDAQ:BLFS) Trading Down 7.7% - Time to Sell?April 1, 2025 | marketbeat.comIntech Investment Management LLC Grows Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)Intech Investment Management LLC lifted its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 164.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,985 shares of the medical equipment provider's stock after purchaMarch 24, 2025 | marketbeat.comProficio Capital Partners LLC Takes $638,000 Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Proficio Capital Partners LLC bought a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 24,584 shares of the medical equipment provideMarch 24, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 346,421 shares of the mMarch 23, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Stock Rating Upgraded by StockNews.comStockNews.com upgraded shares of BioLife Solutions from a "sell" rating to a "hold" rating in a research report on Wednesday.March 20, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sarah Aebersold Sells 2,695 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 2,695 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $25.44, for a total value of $68,560.80. Following the completion of the sale, the insider now directly owns 43,165 shares of the company's stock, valued at $1,098,117.60. The trade was a 5.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.March 20, 2025 | marketbeat.comSarah Aebersold Sells 2,695 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 2,695 shares of the company's stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $25.44, for a total transaction of $68,560.80. Following the completion of the transaction, the insider now owns 43,165 shares in the company, valued at approximately $1,098,117.60. This represents a 5.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.March 19, 2025 | marketbeat.comSarah Aebersold Sells 5,632 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 5,632 shares of BioLife Solutions stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $24.96, for a total transaction of $140,574.72. Following the sale, the insider now owns 45,860 shares of the company's stock, valued at approximately $1,144,665.60. This represents a 10.94 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 19, 2025 | marketbeat.comWilliam Blair Investment Management LLC Trims Position in BioLife Solutions, Inc. (NASDAQ:BLFS)William Blair Investment Management LLC decreased its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 20.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 910,348 shares of the medical equipment provider's stMarch 19, 2025 | marketbeat.comBioLife Solutions Appoints Cathy Coste as Director and Audit Committee ChairMarch 18, 2025 | prnewswire.comRoyce & Associates LP Has $20.18 Million Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Royce & Associates LP lessened its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 5.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 777,282 shares of the medical equipment proMarch 17, 2025 | marketbeat.comRaymond James Financial Inc. Takes $20.66 Million Position in BioLife Solutions, Inc. (NASDAQ:BLFS)Raymond James Financial Inc. bought a new stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 795,998 shares of the medical equipment provider's stock, valued at approximately $20,664,000. RMarch 17, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Holdings in BioLife Solutions, Inc. (NASDAQ:BLFS)Victory Capital Management Inc. raised its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 422.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 218,962 shares of the medical equMarch 16, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Stock Price Down 2.6% on Insider SellingBioLife Solutions (NASDAQ:BLFS) Stock Price Down 2.6% After Insider SellingMarch 15, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 1,091 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) insider Sarah Aebersold sold 1,091 shares of BioLife Solutions stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $25.00, for a total transaction of $27,275.00. Following the completion of the sale, the insider now owns 58,816 shares in the company, valued at $1,470,400. The trade was a 1.82 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.March 14, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CMO Sells 1,577 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 1,577 shares of the stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total value of $39,425.00. Following the transaction, the chief marketing officer now owns 104,961 shares of the company's stock, valued at $2,624,025. The trade was a 1.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.March 14, 2025 | marketbeat.comAby J. Mathew Sells 1,597 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 1,597 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total transaction of $39,925.00. Following the completion of the transaction, the executive vice president now owns 260,601 shares in the company, valued at $6,515,025. The trade was a 0.61 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.March 14, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) CFO Troy Wichterman Sells 4,151 SharesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 4,151 shares of the company's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $25.00, for a total value of $103,775.00. Following the completion of the sale, the chief financial officer now owns 116,809 shares of the company's stock, valued at $2,920,225. This trade represents a 3.43 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.March 14, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) Insider Sells 1,091 Shares of StockMarch 14, 2025 | insidertrades.comQ1 EPS Estimate for BioLife Solutions Raised by AnalystBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at HC Wainwright lifted their Q1 2025 earnings estimates for shares of BioLife Solutions in a research report issued on Wednesday, March 5th. HC Wainwright analyst Y. Chen now anticipates that the medical equipment provider wMarch 10, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of "Buy" by BrokeragesBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average 12-month pricMarch 9, 2025 | marketbeat.comBioLife Solutions (NASDAQ:BLFS) Given New $30.00 Price Target at HC WainwrightHC Wainwright boosted their price objective on shares of BioLife Solutions from $27.00 to $30.00 and gave the company a "buy" rating in a research report on Thursday.March 7, 2025 | marketbeat.comQ1 EPS Estimate for BioLife Solutions Increased by AnalystBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Research analysts at Northland Capmk boosted their Q1 2025 earnings per share estimates for shares of BioLife Solutions in a research note issued on Monday, March 3rd. Northland Capmk analyst C. Byrnes now forecasts that the medical equipmentMarch 7, 2025 | marketbeat.comBioLife Solutions, Inc. (NASDAQ:BLFS) Stake Cut by Geneva Capital Management LLCGeneva Capital Management LLC cut its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 852,741 shares of the medical equipment provider'March 7, 2025 | marketbeat.comTodd Berard Sells 424 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 424 shares of BioLife Solutions stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $25.46, for a total value of $10,795.04. Following the sale, the chief marketing officer now owns 106,538 shares of the company's stock, valued at approximately $2,712,457.48. This trade represents a 0.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.March 6, 2025 | marketbeat.comAby J. Mathew Sells 425 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) EVP Aby J. Mathew sold 425 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $25.46, for a total value of $10,820.50. Following the sale, the executive vice president now owns 262,198 shares in the company, valued at $6,675,561.08. This represents a 0.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 6, 2025 | marketbeat.comInsider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) CFO Sells 660 Shares of StockBioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CFO Troy Wichterman sold 660 shares of the business's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $25.46, for a total value of $16,803.60. Following the transaction, the chief financial officer now directly owns 120,960 shares of the company's stock, valued at $3,079,641.60. The trade was a 0.54 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.March 6, 2025 | marketbeat.comNorthland Capmk Analysts Boost Earnings Estimates for BLFSBioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) - Investment analysts at Northland Capmk increased their Q3 2025 earnings estimates for shares of BioLife Solutions in a research note issued to investors on Monday, March 3rd. Northland Capmk analyst C. Byrnes now anticipates that the medical eMarch 6, 2025 | marketbeat.comTodd Berard Sells 424 Shares of BioLife Solutions, Inc. (NASDAQ:BLFS) StockMarch 6, 2025 | insidertrades.comLake Street Sticks to Its Buy Rating for BioLife Solutions (BLFS)March 6, 2025 | markets.businessinsider.comBioLife Solutions price target raised to $30 from $27 at H.C. WainwrightMarch 6, 2025 | msn.com Remove Ads Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address BLFS Media Mentions By Week BLFS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLFS News Sentiment▼0.760.80▲Average Medical News Sentiment BLFS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLFS Articles This Week▼114▲BLFS Articles Average Week Remove Ads Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Soleno Therapeutics News Today iRhythm Technologies News Today PROCEPT BioRobotics News Today Envista News Today TransMedics Group News Today LivaNova News Today Enovis News Today NovoCure News Today LeMaitre Vascular News Today CONMED News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BLFS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BLFS Stock Free BLFS Stock Alerts